These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12107742)

  • 21. Reciprocal relationships between insulin resistance and endothelial dysfunction: insights from therapeutic interventions.
    Quon MJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):305-12. PubMed ID: 16859113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel actions of thiazolidinediones on vascular function and exercise capacity.
    Reusch JE; Regensteiner JG; Watson PA
    Am J Med; 2003 Dec; 115 Suppl 8A():69S-74S. PubMed ID: 14678869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease.
    Cleland SJ; Petrie JR; Ueda S; Elliott HL; Connell JM
    Clin Exp Pharmacol Physiol; 1998; 25(3-4):175-84. PubMed ID: 9590566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular defects in the aetiology of peripheral insulin resistance in diabetes. A critical review of hypotheses and facts.
    Wiernsperger N
    Diabetes Metab Rev; 1994 Oct; 10(3):287-307. PubMed ID: 7835173
    [No Abstract]   [Full Text] [Related]  

  • 25. Vascular reactivity in diabetes mellitus.
    Chaudhuri A
    Curr Diab Rep; 2002 Aug; 2(4):305-10. PubMed ID: 12643189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance.
    Blaak EE
    Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):391-403. PubMed ID: 16150382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.
    Laakso M; Edelman SV; Brechtel G; Baron AD
    J Clin Invest; 1990 Jun; 85(6):1844-52. PubMed ID: 2189893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional status of vascular endothelium in diabetes mellitus.
    Saboor M; Moinuddin ; Ajmal M; Ilyas S
    J Ayub Med Coll Abbottabad; 2014; 26(2):239-43. PubMed ID: 25603686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT 4 in skeletal muscles.
    Hardin DS; Azzarelli B; Edwards J; Wigglesworth J; Maianu L; Brechtel G; Johnson A; Baron A; Garvey WT
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2437-46. PubMed ID: 7629239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation.
    Båvenholm PN; Kuhl J; Pigon J; Saha AK; Ruderman NB; Efendic S
    J Clin Endocrinol Metab; 2003 Jan; 88(1):82-7. PubMed ID: 12519834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting fatty acid metabolism to improve glucose metabolism.
    Stinkens R; Goossens GH; Jocken JW; Blaak EE
    Obes Rev; 2015 Sep; 16(9):715-57. PubMed ID: 26179344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
    Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free fatty acids and skeletal muscle insulin resistance.
    Kraegen EW; Cooney GJ
    Curr Opin Lipidol; 2008 Jun; 19(3):235-41. PubMed ID: 18460913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free fatty acids and skeletal muscle insulin resistance.
    Rachek LI
    Prog Mol Biol Transl Sci; 2014; 121():267-92. PubMed ID: 24373240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.
    Prior JO; Quiñones MJ; Hernandez-Pampaloni M; Facta AD; Schindler TH; Sayre JW; Hsueh WA; Schelbert HR
    Circulation; 2005 May; 111(18):2291-8. PubMed ID: 15851590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
    Farkas K; Sármán B; Jermendy G; Somogyi A
    Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiazolidinediones--tools for the research of metabolic syndrome X.
    Komers R; Vrána A
    Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-mediated blood flow and glucose uptake.
    Floras JS; Meneilly G
    Can J Cardiol; 2001 May; 17 Suppl A():7A-10A. PubMed ID: 11381287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.